Download PDF
Geburtshilfe Frauenheilkd 2024; 84(11): 1027-1029
DOI: 10.1055/a-2334-1345
GebFra Magazin
Aktuell diskutiert

Zur Rolle von Bakteriozinen der Laktobazillen bei der Regulierung der Vaginalflora

Herbert Hof
› Further Information
Also available at
    Permissions and Reprints

Laktobazillen spielen bekanntlich eine zentrale Rolle beim Schutz der Vagina vor Infektionen. Dieser Effekt beruht auf mehreren Wirkmechanismen. Die Rolle der Bakteriozine dabei ist noch wenig bekannt und erforscht. Man kann davon ausgehen, dass diese bakteriellen Oligopeptide regelmäßig gebildet werden und auch in Synergie mit anderen Abwehrmaßnahmen gegen pathogene Erreger wirken. Das gesamte Ausmaß ihrer Beteiligung an der Homöostase der Vaginalflora ist noch nicht klar abzusehen.

Publication History

Article published online:
07 November 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Mendling W. Vaginale Mikrobiota – ein Update. Gynäkologe 2015; 48: 780-786
    CrossrefPubMedSearch in Google Scholar
  • 2 Borges S, Barbosa J, Teixeira P. Gynecological Health and Probiotics. In: Watson RR, Preedy VR. Probiotics, Prebiotics, and Synbiotics. Bioactive Foods in Health Promotion; Part IV Probiotics in Health. Cambridge, Massachusetts: Academic Press; 2016: 741-752
    CrossrefSearch in Google Scholar
  • 3 Niu XX, Li T, Zhang X. et al. Lactobacillus crispatus modulates vaginal epithelial cell innate response to Candida albicans. Chin Med J (Engl) 2017; 130: 273-279
    CrossrefPubMedSearch in Google Scholar
  • 4 Madanchi H, Shoushtari M, Kashani HH. et al. Antimicrobial peptides of the vaginal innate immunity and their role in the fight against sexually transmitted diseases. New Microbes New Infect 2019; 34: 100627
    CrossrefPubMedSearch in Google Scholar
  • 5 Noda-Nicolau NM, Silva MC, Bento GFC. et al. Cervicovaginal levels of human beta defensins during bacterial vaginosis. PLoS One 2021; 16: e0260753
    CrossrefPubMedSearch in Google Scholar
  • 6 Cohen MS, Britigan BE, French M. et al. Bean K. Preliminary observations on lactoferrin secretion in human vaginal mucus: variation during the menstrual cycle, evidence of hormonal regulation, and implications for infection with Neisseria gonorrhoeae. Am J Obstet Gynecol 1987; 157: 1122-1125
    CrossrefPubMedSearch in Google Scholar
  • 7 Hawes SE, Hillier SL, Benedetti J. et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996; 174: 1058-1063
    CrossrefPubMedSearch in Google Scholar
  • 8 Dover SE, Aroutcheva AA, Faro S. et al. Natural antimicrobials and their role in vaginal health: a short review. Int J Probiotics Prebiotics 2008; 3: 219-230
    PubMedSearch in Google Scholar
  • 9 Hof H. Bacteriocine (inklusive Lantibiotika). Antibakterielle Peptide im Kampf gegen die Verwandtschaft. (mit Exkurs: Mycocine). MT im Dialog 2024; 25: 416-419
    CrossrefPubMedSearch in Google Scholar
  • 10 Klaenhammer TR, Fremaux C, Ahn C, Milton K. Chapter 7 – Molecular Biology of Bacteriocins produced by Lactobacillus. In: Hoover DG, Steenson LR. Bacteriocins of Lactic Acid Bacteria. Cambridge, Massachusetts: Academic Press; 1993: 151-180
    CrossrefSearch in Google Scholar
  • 11 Messaoudi S, Manai M, Kergourlay G. et al. Lactobacillus salivarius: Bacteriocin and probiotic activity. Food Microbiology 2013; 36: 296-304
    CrossrefPubMedSearch in Google Scholar
  • 12 Ocaña VS, Pesce De Ruiz Holgado AA. et al. Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain. Appl Environ Microbiol 1999; 65: 5631-5635
    CrossrefPubMedSearch in Google Scholar
  • 13 Perez RH, Zendo T, Sonomoto K. Multiple bacteriocin production in lactic acid bacteria. J Biosci Bioeng 2022; 134: 277-287
    CrossrefPubMedSearch in Google Scholar
  • 14 Schillinger U, Geisen R, Holzapfel WH. Bakteriozine von Milchsäurebakterien – Eigenschaften, Wirkungsmechanismen und Genetik. Biospektrum 1995; 1: 59-66
    PubMedSearch in Google Scholar
  • 15 Darbandi A, Asadi A, Ari MM. et al. Bacteriocins: properties and potential use as antimicrobials. J Clin Lab Anal 2022; 36: e24093
    CrossrefPubMedSearch in Google Scholar
  • 16 Kaewsrichan J, Peeyananjarassri K, Kongprasertkit J. Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens. FEMS Immunol Med Microbiol 2006; 48: 75-83
    CrossrefPubMedSearch in Google Scholar
  • 17 Voravuthikunchai SP, Bilasoi S, Supamala O. Antagonistic activity against pathogenic bacteria by human vaginal lactobacilli. Anaerobe 2006; 12: 221-226
    CrossrefPubMedSearch in Google Scholar
  • 18 Aroutcheva A, Simoes JA, Faro S. Antimicrobial protein produced by vaginal Lactobacillus acidophilus that inhibits Gardnerella vaginalis. Infect Dis Obstet Gynecol 2001; 9: 33-39
    CrossrefPubMedSearch in Google Scholar
  • 19 Ferraboschi P, Ciceri S, Grisenti P. Applications of Lysozyme, an innate immune defense factor, as an alternative antibiotic. Antibiotics (Basel) 2021; 10: 1534
    CrossrefPubMedSearch in Google Scholar
  • 20 Mei Z, Li D. The role of probiotics in vaginal health. Front Cell Infect Microbiol 2022; 12: 963868
    CrossrefPubMedSearch in Google Scholar
  • 21 Jang SJ, Lee K, Kwon B. et al. Vaginal lactobacilli inhibit growth and hyphae formation of Candida albicans. Sci Rep 2019; 9: 8121
    CrossrefPubMedSearch in Google Scholar
  • 22 Abbe C, Mitchell CM. Bacterial vaginosis: a review of approaches to treatment and prevention. Front Reprod Health 2023; 5: 1100029
    CrossrefPubMedSearch in Google Scholar
  • 23 AnjanaTiwari SK. Bacteriocin-producing probiotic lactic acid bacteria in controlling dysbiosis of the gut microbiota. Front Cell Infect Microbiol 2022; 12: 851140
    CrossrefPubMedSearch in Google Scholar
  • 24 Huang F, Teng K, Liu Y. et al. Bacteriocins: potential for human health. Oxid Med Cell Longev 2021; 2021: 5518825
    CrossrefPubMedSearch in Google Scholar